Wilms Tumor Ppt New
Based on the status at 11p15 and WT1, Wilms tumors can be stratified into three molecular groups:
| Stage | Description | |-------|-------------| | | Tumor limited to kidney, completely resected | | Stage II | Tumor extends beyond kidney but completely resected | | Stage III | Residual non-hematogenous tumor confined to abdomen | | Stage IV | Hematogenous metastases (lung, liver, bone, brain) | | Stage V | Bilateral renal involvement at diagnosis |
Initial diagnosis begins with imaging. Ultrasonography is typically the first step to confirm the presence of a renal mass and evaluate the patency of the renal vein and inferior vena cava. wilms tumor ppt new
A novel Cancer Stemness Prognostic Index (CSPI) was developed using machine learning algorithms to stratify WT patients by risk and histological subtype. Targeting REN offers promising therapeutic opportunities for high-risk WT cases by simultaneously inhibiting tumor progression and restoring immune function.
Tumor extends beyond the kidney (into perirenal soft tissues or local blood vessels) but is completely resected with negative margins. Based on the status at 11p15 and WT1,
: More frequent in African American children and slightly more common in girls. 2. Etiology & Pathogenesis Wilms Tumor - StatPearls - NCBI Bookshelf - NIH
Wilms tumor accounts for approximately 90 percent of all pediatric kidney tumors. It primarily affects children between the ages of three and four, with most cases diagnosed before age five. While the majority of cases are sporadic, about 10 percent are associated with specific genetic syndromes. wilms tumor ppt new
: Characterized by a classic triphasic pattern containing blastemal, epithelial, and stromal cells.
Defined by the triad of early-onset nephrotic syndrome (diffuse mesangial sclerosis), male pseudohermaphroditism, and a high risk of Wilms tumor due to specific missense mutations in the WT1 gene. WT2-Related Syndromes (Chromosome 11p15.5)
: Actinomycin D (Dactinomycin) and Vincristine form the backbone for low-risk, early-stage disease.